Korea Developing AI Drug Reviews, Unveils National Biopharma AI Strategy

Aims To Boost Drug Pipeline 10x In Five Years

 
• By Jung Won Shin
  
AI
AI Drug Review System, A Key Starting Point Of The Shift To Regulatory Science-Based AI (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from AI

More from Advanced Technologies